A research collaboration between the universities of Oslo and Aarhus has resulted in the development of a new method with diagnostic potential. The new method that combines phase extraction with an enzymatic reaction may eventually be used for an improved and faster screening analysis of isatin as a potential indicator of stress and neurological disorders. The study is published in the journal ACS Chemical Neuroscience.
The team explain that isatin is a small organic molecule found in low concentrations in different tissues and is excreted with the urine via the blood stream. Isatin is supposedly a degradation product from the neurotransmitters, e.g. dopamine and serotonine.
Previous studies show that the level of isatin is elevated in patients suffering from stress and in patients suffering from Parkinson’s disease. The level of isatin is also elevated among pregnant women. Isatin is an inhibitor of monoamine oxidase B, an enzyme that catalyses the initial degradation of dopamine and serotonine. This inhibitory effect makes isatin act as an antidepressant, and it relieves the symptoms of patients suffering from Parkinson’s.
The team are the prime movers in the development of this highly specific method to determine the concentration of isatin in samples of blood and urine, using the bacterial enzyme isatin hydrolase in combination with a two-phase extraction. Isatin hydrolase catalyses the conversion of isatin into isatinate, which is followed by a chemical conversion of isatinate into the fluorescent compound anthranilate.
The data findings show that the method can be refined further by substituting the chemical step by an enzyme that is able to convert isatinate into anthranilate.
The researchers stress that within several bacterial species, isatin is formed via the degradation of indole 3-acetic acid, however, the origin of isatin in humans are not known. The team’s method to detect isatin might be useful in future experiments to establish the source-tissue and precursors for isatin formation.
Source: University of Oslo
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.